It can be seen that puerarin has a good therapeutic prospect in improving AD cognitive dysfunction, and its mechanism is closely related to PI3K/Akt-mediated anti-apoptosis and antioxidant. This evidence concerns the gene AKT1 and Alzheimer disease.